Medical Innovation Act of 2024

Cost and committee reports

Official records Congress.gov attaches to H.R. 10238.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Ms. SCHAKOWSKY, as printed in the Congressional Record (Vol. 170, No. 173, November 21, 2024, Page H6193):
  Section 8 of article 1 of the Constitution The single subject of this legislation is: The bill amends the Public Health Service Act to require certain drug manufacturers to make payments to fund research supported by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH).
  Source: Congress.gov, Congressional Record November 21, 2024 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  300 characters

  Congress.gov bill record

  H.R. 10238, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/10238

  Record last updated by Congress.gov

  December 5, 2025

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  b42f01cc321eca78f1a54140d1a4b919a3a5c7508f4309eb28185fe1933d350a

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of December 5, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 10238, last updated December 5, 2025. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.